The EGFR pathway is involved in the regulation of ABCG2 expression and function [50]; in fact, EGFR inhibition led to the reversal of ABCG2-mediated chemoresistance in in vitro and tumor models [51]. This evidence concerns the gene ABCG2 and neoplasm.